Current NDC auxiliary source row compounder:152

This page is keyed by dataset, FDA.report source record ID, and physical source row number. Empty values are shown rather than omitted.

Complete normalized row#

Record Source: ndc_compounder_zip
Product Ndc Raw: 83826-9004
Product Ndc: 83826-9004
Product Ndc Digits: 838269004
Product Type Name: HUMAN COMPOUNDED DRUG
Proprietary Name: Dexamethasone phosphate, Moxiflocacin HCl
Proprietary Name Suffix: [empty]
Nonproprietary Name: Dexamethasone phosphate 0.1%, Moxiflocacin HCl 0.5%
Dosage Form Name: SOLUTION
Route Name: INTRACAMERAL; OPHTHALMIC
Marketing Category Name: OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)
Labeler Name: OSRX, Inc.
Establishment Name: OSRX, Inc.
Establishment Fei: [empty]
Substance Name: MOXIFLOXACIN HYDROCHLORIDE; DEXAMETHASONE SODIUM PHOSPHATE
Active Ingredients Info: 5 mg/1 mL; 1 mg/1 mL
History Active Ingredients Raw: MOXIFLOXACIN HYDROCHLORIDE; DEXAMETHASONE SODIUM PHOSPHATE
History Active Ingredients Info Raw: 5 mg/1 mL; 1 mg/1 mL
History Dosage Raw: SOLUTION
Dea Schedule: [empty]
Package Ndc Raw: 83826-9004-1
Package Ndc: 83826-9004-1
Package Ndc Digits: 8382690041
Package Ndc11: 83826900401
Package Description: 1 mL in 1 VIAL (83826-9004-1)
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Normalization Status: valid
Source Url: https://www.accessdata.fda.gov/cder/compounders_ndc_directory.zip
Source Archive: compounders_ndc_directory.zip
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Last Modified: Fri, 18 Sep 2026 15:17:23 GMT
Source Archive Sha256: 222f6800f79cb1a0fa79431b7226bd6b34899999dbf086af51004a96774ada98
Source Member Sha256: f8d9743e5616579a34d614887e86a53913efa0a63d3138d59d2f87cbb4d0cc17
Source Record Id: compounder:152
Source Row Number: 152
Source Row Hash: 731eb37f6957d97d22f34909f559321f8ab25a13a5a5eb90cde8c5efb2b46c96
Import Run Id: 20261015T130142Z
Loaded At: 2026-10-15 13:06:14

Exact raw FDA source fields#

{
    "ROUTENAME": "INTRACAMERAL; OPHTHALMIC",
    "PRODUCTNDC": "83826-9004",
    "DEASCHEDULE": "",
    "LABELERNAME": "OSRX, Inc.",
    "SUBSTANCENAME": "MOXIFLOXACIN HYDROCHLORIDE; DEXAMETHASONE SODIUM PHOSPHATE",
    "DOSAGEFORMNAME": "SOLUTION",
    "NDCPACKAGECODE": "83826-9004-1",
    "PRODUCTTYPENAME": "HUMAN COMPOUNDED DRUG",
    "PROPRIETARYNAME": "Dexamethasone phosphate, Moxiflocacin HCl",
    "REPORTINGPERIOD": "2026-1",
    "NONPROPRIETARYNAME": "Dexamethasone phosphate 0.1%, Moxiflocacin HCl 0.5%",
    "PACKAGEDESCRIPTION": "1 mL in 1 VIAL (83826-9004-1) ",
    "ACTIVEINGREDIENTSINFO": "5 mg/1 mL; 1 mg/1 mL",
    "MARKETINGCATEGORYNAME": "OUTSOURCING FACILITY COMPOUNDED HUMAN DRUG PRODUCT (EXEMPT FROM APPROVAL REQUIREMENTS)",
    "PROPRIETARYNAMESUFFIX": ""
}

Normalization notes#

[]

Current status projection#

Dataset: compounder
Record Source: ndc_compounder_zip
Source Record Id: compounder:152
Source Row Number: 152
Status Scope: package
Lookup Ndc: 83826-9004-1
Lookup Ndc Digits: 8382690041
Product Ndc: 83826-9004
Product Ndc Digits: 838269004
Package Ndc: 83826-9004-1
Package Ndc Digits: 8382690041
Package Ndc11: 83826900401
Product Id: [empty]
Status Code: COMPOUNDER
Status Label: Outsourcing facility compounded drug report
Reporting Period Raw: 2026-1
Reporting Period: 2026-1
Source Table: fda_ndc_aux_compounder
Source File: compounders_ndc_directory.txt
Source Date: 2026-09-18
Source Row Hash: 731eb37f6957d97d22f34909f559321f8ab25a13a5a5eb90cde8c5efb2b46c96
Import Run Id: 20261015T130142Z
Loaded At: 2026-10-15 13:06:14